Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of V(L) and V(H) Domains Targeting CD123(+) Tumors

Adoptive immunotherapy infusing T cells with engineered specificity for CD19 expressed on B- cell malignancies is generating enthusiasm to extend this approach to other hematological malignancies, such as acute myelogenous leukemia (AML). CD123, or interleukin 3 receptor alpha, is overexpressed on m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Thokala, Radhika, Olivares, Simon, Mi, Tiejuan, Maiti, Sourindra, Deniger, Drew, Huls, Helen, Torikai, Hiroki, Singh, Harjeet, Champlin, Richard E., Laskowski, Tamara, McNamara, George, Cooper, Laurence J. N.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4993583/
https://ncbi.nlm.nih.gov/pubmed/27548616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0159477
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars